115 related articles for article (PubMed ID: 11844873)
1. In utero exposure to immunosuppressive drugs.
Prévot A; Martini S; Guignard JP
Biol Neonate; 2002; 81(2):73-81. PubMed ID: 11844873
[TBL] [Abstract][Full Text] [Related]
2. [Exposure in utero to immunosuppressives].
Prévot A; Martini S; Guignard JP
Rev Med Suisse Romande; 2001 Apr; 121(4):283-91. PubMed ID: 11400400
[TBL] [Abstract][Full Text] [Related]
3. In utero exposure to immunosuppressive drugs: experimental and clinical studies.
Tendron A; Gouyon JB; Decramer S
Pediatr Nephrol; 2002 Feb; 17(2):121-30. PubMed ID: 11875675
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of children exposed antenatally to immunosuppressive drugs.
Motta M; Tincani A; Meroni PL; Cimaz R
Rheumatology (Oxford); 2008 Jun; 47 Suppl 3():iii32-4. PubMed ID: 18504283
[TBL] [Abstract][Full Text] [Related]
5. Neonates born from mothers with autoimmune disorders.
Motta M; Rodriguez-Perez C; Tincani A; Lojacono A; Nacinovich R; Chirico G
Early Hum Dev; 2009 Oct; 85(10 Suppl):S67-70. PubMed ID: 19765919
[TBL] [Abstract][Full Text] [Related]
6. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
Laskowska M; Laskowska K; Oleszczuk J
J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
[TBL] [Abstract][Full Text] [Related]
7. Increased morbidity in severe early intrauterine growth restriction.
Aucott SW; Donohue PK; Northington FJ
J Perinatol; 2004 Jul; 24(7):435-40. PubMed ID: 15116139
[TBL] [Abstract][Full Text] [Related]
8. [Postnatal growth of very low birth weight infants during hospitalization].
Collaborative Group for the Nutritional, Growth and Developmental Study on Very Low Birth Weight Infants
Zhonghua Er Ke Za Zhi; 2013 Jan; 51(1):4-11. PubMed ID: 23527924
[TBL] [Abstract][Full Text] [Related]
9. Safety of tacrolimus in pregnancy.
Nevers W; Pupco A; Koren G; Bozzo P
Can Fam Physician; 2014 Oct; 60(10):905-6. PubMed ID: 25316742
[TBL] [Abstract][Full Text] [Related]
10. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
11. Effects of maternally administered drugs on the fetal and neonatal kidney.
Boubred F; Vendemmia M; Garcia-Meric P; Buffat C; Millet V; Simeoni U
Drug Saf; 2006; 29(5):397-419. PubMed ID: 16689556
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy outcome post renal transplantation.
Sgro MD; Barozzino T; Mirghani HM; Sermer M; Moscato L; Akoury H; Koren G; Chitayat DA
Teratology; 2002 Jan; 65(1):5-9. PubMed ID: 11835226
[TBL] [Abstract][Full Text] [Related]
13. [Intrauterine growth retardation--perinatal mortality and postnatal morbidity in a perinatal center].
Meyberg R; Boos R; Babajan A; Ertan AK; Schmidt W
Z Geburtshilfe Neonatol; 2000; 204(6):218-23. PubMed ID: 11199150
[TBL] [Abstract][Full Text] [Related]
14. The very low birthweight infant: maternal complications leading to preterm birth, placental lesions, and intrauterine growth.
Salafia CM; Ernst LM; Pezzullo JC; Wolf EJ; Rosenkrantz TS; Vintzileos AM
Am J Perinatol; 1995 Mar; 12(2):106-10. PubMed ID: 7779189
[TBL] [Abstract][Full Text] [Related]
15. Prematurity and intrauterine growth retardation--double jeopardy?
Regev RH; Reichman B
Clin Perinatol; 2004 Sep; 31(3):453-73. PubMed ID: 15325532
[TBL] [Abstract][Full Text] [Related]
16. Administration of Antithymocyte Globulin (Rabbit) to Treat a Severe, Mixed Rejection Episode in a Pregnant Renal Transplant Recipient.
Kutzler HL; Ye X; Rochon C; Martin ST
Pharmacotherapy; 2016 Apr; 36(4):e18-22. PubMed ID: 26892892
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive therapy, management, and outcome of heart transplant recipients during pregnancy.
Wagoner LE; Taylor DO; Olsen SL; Price GD; Rasmussen LG; Larsen CB; Scott JR; Renlund DG
J Heart Lung Transplant; 1993; 12(6 Pt 1):993-9; discussion 1000. PubMed ID: 8312325
[TBL] [Abstract][Full Text] [Related]
18. [Risk factors for low birth weight and intrauterine growth retardation in Santiago, Chile].
Vega J; Sáez G; Smith M; Agurto M; Morris NM
Rev Med Chil; 1993 Oct; 121(10):1210-9. PubMed ID: 8191127
[TBL] [Abstract][Full Text] [Related]
19. Short-term and long-term sequelae in intrauterine growth retardation (IUGR).
Longo S; Bollani L; Decembrino L; Di Comite A; Angelini M; Stronati M
J Matern Fetal Neonatal Med; 2013 Feb; 26(3):222-5. PubMed ID: 23030765
[TBL] [Abstract][Full Text] [Related]
20. Azathioprine during pregnancy in systemic lupus erythematosus patients is not associated with poor fetal outcome.
Saavedra MÁ; Sánchez A; Morales S; Ángeles U; Jara LJ
Clin Rheumatol; 2015 Jul; 34(7):1211-6. PubMed ID: 26050103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
